Longhorn Vaccines and Diagnostics, a One Health company developing vaccines and diagnostic tools for global animal and public health, announced today ...

Atonarp is a pioneer in the digital transformation of molecular diagnostics in pharma, semiconductor manufacturing, industrial process control, and now in the life sciences sector. The company ...

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of diagnostic tests, announced today the launch of their Vector Smart™ NAM-e multiplex ...

The growing prevalence of multidrug-resistant bacteria (MDRB) presents a significant global health challenge, complicating infectious disease treatment and ...

ZeptoMetrix, part of Antylia Scientific, specializes in infectious disease diagnostic solutions and quality control materials for the molecular diagnostics market.

Eastern Europe Molecular Diagnostics Market to reach US$ 1.6 Bn by 2035, growing at 3.2% CAGR, driven by advanced testing adoption and healthcare expansion. WILMINGTON, DE, UNITED STATES, August 23, ...

Co-Diagnostics, Inc., a Utah corporation, is a molecular diagnostics company with a proprietary diagnostic testing technology and development platform that intends to manufacture and sell reagents ...

Bringing sensitive TB diagnosis and drug susceptibility testing closer to patients is a key priority for global TB control, but requires robust point-of-care diagnostic tests that are easily ...

Over the past few months, the Molecular Diagnostics market has been prospering well on the back of the COVID-19 havoc, followed by the surge in Monkeypox cases. Apart from these instances, the ...